Skip to main content
Premium Trial:

Request an Annual Quote

Biological Dynamics Signs Tech Access Deal With OHSU

NEW YORK (GenomeWeb) – Biological Dynamics announced today that has agreed to provide early access to its NanoVerita and ExoVerita lab-on-a-chip systems to researchers at the Knight Cancer Institute at Oregon Health & Science University (OHSU).

NanoVerita provides a sample-to-answer workflow for the isolation and fluorescent imaging of macromolecular targets such as cell-free DNA, while ExoVerita is designed to isolate and analyze extracellular vesicles to support assay development. Both use Biological Dynamics' AC electrokinetics, or ACE, technology for reversible macromolecule capture.

Under the terms of the deal, Biological Dynamics will provide early access to the NanoVerita and ExoVerita platforms to researchers at OHSU's Cancer Early Detection Advanced Research (CEDAR) Center. Additional terms were not disclosed.

"By collaborating with industry partners, we can access emerging technologies that can accelerate our research efforts," CEDAR Center Codirector Paul Spellman said in a statement. "We were impressed with the ability of Biological Dynamics' lab-on-chip platforms to quickly and simultaneously isolate DNA, RNA, and exosomal biomarkers, as well as scale as the project progresses to clinical validation. We will work with the team at Biological Dynamics to research new methods to detect and eliminate lethal cancers early."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.